Abbott Receives FDA Clearance for Cataract Surgery Protective Gel

Abbott has announced it has received FDA clearance for its Healon EndoCoat OVD, according to a news release.

Advertisement

 

Part of Abbott’s Healon family of ophthalmic viscosurgical devices, the device intended for use as a surgical aid in cataract extraction and intraocular lens implantation.

 

It is a clear, viscous, protective gel formula that is intended to be injected into a patient’s eye to protect and coat the eye during surgery.

 

“Healon OVDs offer the surgeon the ultimate in control, clarity and ease-of-use during every step of the cataract procedure,” said Jim Mazzo, senior vice president, Abbott Medical Optics, in the release. “The U.S. approval of Healon EndoCoat OVD adds to a reliable portfolio of OVDs that has been known and trusted for more than 25 years and proven safe worldwide.”

 

Abbott is headquartered in Chicago.

 

Related Articles on FDA Clearances:

ProPep Surgical Receives FDA Clearance for Nerve Monitoring System

Ultrasonix Medical Receives FDA Approval for Needle Guidance Technology

Synergetics Receives FDA Clearance for Versavit Vitrectomy System

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.